首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1274328

克隆和诱变全球市场研究报告——2023-2030 年行业分析、规模、份额、增长、趋势和预测

Global Cloning And Mutagenesis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年04月01日 | 出版商:

Value Market Research | 英文 177 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

在 2023 年至 2030 年的研究期间，全球对克隆和诱变市场的需求将以 10.52% 的复合年增长率增长，从 2022 年的 62.6 亿美元增长到 2030 年的近 139.3 亿美元，预计将达到规模。

克隆和诱变是指用于研究蛋白质功能、结构以及体外和体内突变影响的技术。克隆是一种涉及通过自然或人工手段创造复製品或相同生物体或实体的技术。它是使用生物技术方法完成的。诱变是一种改变生物体遗传信息，导致基因突变的技术。它是通过在实验室中操纵突变来在生物体中产生突变基因来完成的。克隆试剂盒用于基因治疗、基因分析和生物製药等各个领域。

市场动态：

慢性病和遗传病患病率上升是推动克隆和诱变市场需求的主要因素。对个性化医疗不断增长的需求促进了这一市场的增长。包括 PCR 在内的克隆和诱变工具的引入刺激了对该市场的需求。持续的技术创新、对用于药物开发的蛋白质工程的日益关注以及对与 HIV 和癌症等疾病相关的研发投资的增加正在推动对该市场的需求。政府机构增加对医学研究的资助、战略合作以及全球生物技术行业的发展正在推动市场需求。

这份研究报告描述了波特的五力模型、市场吸引力分析和价值链分析。这些工具可帮助您清楚地了解您的行业结构并评估您在全球范围内的竞争吸引力。此外，这些工具还能够全面评估全球克隆和诱变市场的每个细分市场。克隆和诱变行业的发展和趋势为这项研究提供了一种整体方法。

市场细分：

克隆和诱变市场细分提供有关国家/地区级别细分的详细数据，以确定每种产品/服务的目标受众并支持未来的商机。

按产品

克隆试剂盒
诱变试剂盒
其他

技术

TopoPCR 克隆
平端克隆
无缝克隆
定点诱变
其他

由最终用户

生物製药和製药公司
首席风险官/首席营销官
学术和研究机构

按地区分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲、中东和非洲的克隆和诱变市场当前和未来的需求。此外，该报告重点关注所有主要地区每个单独应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况和全球竞争格局的详细视图。克隆和诱变市场的主要参与者是 Takara Bio Inc.、Agilent Technologies Inc.、Thermo Fisher Scientific Inc.、New England Biolabs、Merck KGaA、Promega Corporation、Bio-Rad Laboratories Inc、Danaher、Jena Bioscience GmbH，这三个公司是 Assay Genie 和 TransGen Biotech Co. Ltd. 本节包括对竞争格局的全面了解，包括各种战略发展，例如主要併购、未来能力、合作伙伴关係、财务概览、合作、新产品开发和新产品发布。

内容

第一章前言

本报告的内容
- 目的
- 目标受众
- 独特的销售建议 (USP) 和提供的服务
调查范围
调查方法
- 市场调研过程
- 市场研究方法

第 2 章执行摘要

市场亮点
全球市场概况

第3章克隆与诱变-行业分析

简介 - 市场动态
市场驱动因素
市场製约因素
市场机会
行业趋势
波特的五力分析
市场吸引力分析
- 按产品分类的市场吸引力分析
- 按技术进行市场吸引力分析
- 按市场进行的吸引力分析：按最终用户
- 市场吸引力分析：按地区

第四章价值链分析

价值链分析
原材料分析
- 成分錶
- 原材料製造商列表
- 主要原材料价格走势
潜在买家名单
营销渠道
- 直接营销
- 间接营销
- 营销渠道趋势

第 5 章 COVID-19 爆发的影响分析

第 6 章克隆和突变全球产品市场分析

产品概览
实际数据和预测数据
按产品分析
克隆试剂盒
诱变试剂盒
其他

第 7 章克隆和诱变全球市场分析：按技术分类

技术概述
历史和预测数据
技术分析
拓扑聚合□链反应克隆
平端克隆
无缝克隆
定点诱变
其他

第 8 章最终用户的全球克隆和诱变剂加工市场销售分析

最终用户总结
实际数据和预测数据
最终用户分析
生物製药和製药公司
首席风险官/首席营销官
学术和研究机构

第 9 章按地区分列的克隆和诱变市场全球销售分析

按地区进行的销售前景分析
介绍销售分析
北美销售分析
- 概览、历史和预测销售分析
- 北美各部门的销售分析
- 北美销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史和预测销售分析
- 按细分市场进行的欧洲销售分析
- 按国家/地区划分的欧洲销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 意大利销售分析
- 俄罗斯销售分析
- 其他欧洲销售分析
亚太地区销售分析
- 概览、历史和未来销售分析
- 亚太地区各部门的销售分析
- 亚太国家/地区销售分析
- 在中国的销售分析
- 印度销售分析
- 日本的销售分析
- 韩国销售分析
- 澳大利亚销售分析
- 其他亚太地区销售分析
拉丁美洲销售分析
- 概览、历史和未来销售分析
- 拉丁美洲各部门的销售分析
- 拉丁美洲国家/地区的销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利的销售分析
- 其他拉丁美洲销售分析
中东和非洲销售分析
- 概览、历史和未来销售分析
- 中东/非洲地区的销售分析
- 中东和非洲国家/地区的销售分析
- 沙特阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 其他中东和非洲销售分析

第10章克隆诱变公司的竞争格局

克隆诱变市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第11章公司简介

前 10 名公司的市场份额分析
市场集中度
Takara Bio Inc.
- 公司简介
- 企业收入
- 产品介绍
- 近期发展状况
安捷伦科技公司
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
Thermo Fisher Scientific Inc.
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
新英格兰生物实验室
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
默克公司
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
普罗米加公司
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
Bio-Rad 实验室公司
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
丹纳赫
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
耶拿生物科学有限公司
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
化验精灵
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
TransGen Biotech Co. Ltd.
- 公司简介
- 企业收入
- 产品信息
- 近期趋势

注意：公司简介中的财务细节和近期发展基于可用信息，可能不包括私营公司。

简介目录图表

Product Code: VMR112110321

The global demand for Cloning And Mutagenesis Market is presumed to reach the market size of nearly USD 13.93 BN by 2030 from USD 6.26 BN in 2022 with a CAGR of 10.52% under the study period 2023 - 2030.

Cloning and mutagenesis refer to the techniques used to study the functions or structure of proteins and the effect of a mutation in vitro and in vivo. Cloning is a technique which includes the creation of a replica or identical organism or entity by natural or artificial means. It is done with the help of biotechnology methods. Mutagenesis is a technique in which the genetic information of an organism is altered and results in the mutation of genes. It is performed in the lab where mutations are engineered to produce mutant genes of an organism. Cloning kits are used in various fields, such as gene therapy, gene analysis, biopharmaceutical, etc.

Market Dynamics:

The rising prevalence of chronic and genetic diseases is the key factor driving the demand for cloning and the mutagenesis market. Growing demand for personalized medicines is contributing to the growth of this market. The adoption of cloning and mutagenesis tools, including PCR is surging the demand for this market. Continuous innovation in technology, coupled with a rising focus on protein engineering for drug development and growing investment in research and development associated with diseases like HIV and cancer, are propelling the demand for this market. Rising funding by government organizations for medical research, strategic collaborations and the rise in biotechnology industries all over the world are boosting the demand for this market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cloning and mutagenesis. The growth and trends of cloning and mutagenesis industry provide a holistic approach to this study.

Market Segmentation:

This section of the cloning and mutagenesis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Cloning Kits
Mutagenesis Kits
Others

By Technology

Topo PCR Cloning
Blunt End Cloning
Seamless Cloning
Site-Directed Mutagenesis
Others

By End-User

Biopharmaceutical & Pharmaceutical Companies
CROs & CMOs
Academic & Research Institutes

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Cloning And Mutagenesis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cloning and mutagenesis market include Takara Bio Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., New England Biolabs, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc., Danaher, Jena Bioscience GmbH, Assay Genie, TransGen Biotech Co. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CLONING AND MUTAGENESIS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL CLONING AND MUTAGENESIS MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Cloning Kits Historic and Forecast Sales by Regions
6.5 Mutagenesis Kits Historic and Forecast Sales by Regions
6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL CLONING AND MUTAGENESIS MARKET ANALYSIS BY TECHNOLOGY

7.1 Overview by Technology
7.2 Historical and Forecast Data
7.3 Analysis by Technology
7.4 Topo PCR Cloning Historic and Forecast Sales by Regions
7.5 Blunt End Cloning Historic and Forecast Sales by Regions
7.6 Seamless Cloning Historic and Forecast Sales by Regions
7.7 Site-directed Mutagenesis Historic and Forecast Sales by Regions
7.8 Others Historic and Forecast Sales by Regions

8 . GLOBAL CLONING AND MUTAGENESIS MARKET SALES ANALYSIS BY END-USER

8.1 Overview by End-user
8.2 Historical and Forecast Data
8.3 Analysis by End-user
8.4 Biopharmaceutical & Pharmaceutical Companies Historic and Forecast Sales by Regions
8.5 CROs & CMOs Historic and Forecast Sales by Regions
8.6 Academic & Research Institutes Historic and Forecast Sales by Regions

9 . GLOBAL CLONING AND MUTAGENESIS MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CLONING AND MUTAGENESIS COMPANIES

10.1. Cloning And Mutagenesis Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF CLONING AND MUTAGENESIS INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Takara Bio Inc.
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Agilent Technologies Inc.
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Thermo Fisher Scientific Inc.
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. New England Biolabs
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Merck KGaA
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Promega Corporation
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Bio-Rad Laboratories Inc.
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Danaher
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Jena Bioscience GmbH
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Assay Genie
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. TransGen Biotech Co. Ltd.
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

简介目录图表